(Q38476237)

3 September 2017

Cancer risk among statin users: a population-based cohort study (English)

1 reference

3 September 2017

8

1 reference

3 September 2017

Susanne Oksbjerg Dalton

6

object named as

Susanne O Dalton

0 references

Henrik Toft Sørensen

object named as

Henrik T Sørensen

7

0 references

Aslak Harbo Poulsen

2

object named as

Aslak H Poulsen

1 reference

3 September 2017

4

Joseph K McLaughlin

1 reference

3 September 2017

Søren Friis

1

1 reference

3 September 2017

Søren P Johnsen

3

1 reference

3 September 2017

Jon P Fryzek

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

International Journal of Cancer

3 September 2017

1 reference

3 September 2017

114

1 reference

3 September 2017

643-647

1 reference

3 September 2017

4

1 reference

Statins and the risk of dementia

3 September 2017

1 reference

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

HMG-CoA reductase inhibitors and the risk of fractures

21 January 2018

1 reference

Hip fracture risk in statin users--a population-based Danish case-control study.

21 January 2018

1 reference

Carcinogenicity of lipid-lowering drugs

21 January 2018

1 reference

Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells

21 January 2018

1 reference

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

21 January 2018

1 reference

Lovastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, induces apoptosis and differentiation in human anaplastic thyroid carcinoma cells.

21 January 2018

1 reference

Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line

21 January 2018

1 reference

Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models

21 January 2018

1 reference

Statins can inhibit proliferation of human breast cancer cells in vitro

21 January 2018

1 reference

HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2

21 January 2018

1 reference

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

21 January 2018

1 reference

Do statins cause cancer? A meta-analysis of large randomized clinical trials

21 January 2018

1 reference

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

21 January 2018

1 reference

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

21 January 2018

1 reference

Lipid-Lowering Medication and Risk of Cancer

21 January 2018

1 reference

Statin use, hyperlipidaemia, and the risk of breast cancer

21 January 2018

1 reference

Statin use and the risk of breast and prostate cancer

21 January 2018

1 reference

Statin use and cancer risk in the General Practice Research Database

21 January 2018

1 reference

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

21 January 2018

1 reference

Use of lipid-lowering drugs during 1991-98 in Northern Jutland, Denmark

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark.

21 January 2018

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.20758

1 reference

3 September 2017

1 reference